Literature DB >> 2159292

NG-amino-L-arginine: a new potent antagonist of L-arginine-mediated endothelium-dependent relaxation.

J M Fukuto1, K S Wood, R E Byrns, L J Ignarro.   

Abstract

This study examined the influence of NG-amino-L-arginine, a novel structural analog of L-arginine, on endothelium-dependent relaxation, contraction, and cyclic GMP accumulation in isolated rings of bovine pulmonary artery. NG-Amino-L-arginine caused potent and stereoselective endothelium-dependent contraction that was associated with a marked and endothelium-dependent decline in basal levels of cyclic GMP in smooth muscle. NG-Amino-L-arginine caused concentration-dependent, competitive, and stereoselective antagonism of acetylcholine-elicited relaxation and cyclic GMP accumulation. NG-Amino-L-arginine was 100- to 300- fold more potent than NG-methyl-L-arginine and did not inhibit endothelium-independent relaxation elicited by nitroglycerin. This potent inhibitory analog of L-arginine should be a useful chemical probe for studying the biosynthesis and biological role of L-arginine-derived nitric oxide both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159292     DOI: 10.1016/0006-291x(90)92343-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  L-arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation.

Authors:  H Moritoki; H Ueda; T Yamamoto; T Hisayama; S Takeuchi
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 2.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 3.  Nitric oxide synthases in mammals.

Authors:  R G Knowles; S Moncada
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

4.  Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers.

Authors:  P F Chen; A L Tsai; V Berka; K K Wu
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

5.  Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.

Authors:  J M Griscavage; S Wilk; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse.

Authors:  P K Moore; A O Oluyomi; R C Babbedge; P Wallace; S L Hart
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

7.  N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.

Authors:  J P Cobb; C Natanson; W D Hoffman; R F Lodato; S Banks; C A Koev; M A Solomon; R J Elin; J M Hosseini; R L Danner
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

Review 8.  Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.

Authors:  Inken Lorenzen; Lisa Mullen; Sander Bekeschus; Eva-Maria Hanschmann
Journal:  Oxid Med Cell Longev       Date:  2017-10-08       Impact factor: 6.543

Review 9.  Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges.

Authors:  Jan Víteček; Antonín Lojek; Giuseppe Valacchi; Lukáš Kubala
Journal:  Mediators Inflamm       Date:  2012-09-04       Impact factor: 4.711

Review 10.  Nitric Oxide Synthase Inhibitors as Antidepressants.

Authors:  Gregers Wegener; Vallo Volke
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.